Mayuko Kondo

1.4k total citations · 1 hit paper
32 papers, 977 citations indexed

About

Mayuko Kondo is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Mayuko Kondo has authored 32 papers receiving a total of 977 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hepatology, 16 papers in Epidemiology and 11 papers in Surgery. Recurrent topics in Mayuko Kondo's work include Liver Disease Diagnosis and Treatment (12 papers), Hepatocellular Carcinoma Treatment and Prognosis (10 papers) and Hepatitis C virus research (9 papers). Mayuko Kondo is often cited by papers focused on Liver Disease Diagnosis and Treatment (12 papers), Hepatocellular Carcinoma Treatment and Prognosis (10 papers) and Hepatitis C virus research (9 papers). Mayuko Kondo collaborates with scholars based in Japan, Australia and United States. Mayuko Kondo's co-authors include Kazuhiko Koike, Ryosuke Tateishi, Naoto Fujiwara, Hayato Nakagawa, Kenichiro Enooku, Tatsuya Minami, Masaya Sato, Yuji Kondo, Yoshinari Asaoka and Koji Uchino and has published in prestigious journals such as PLoS ONE, Scientific Reports and Journal of Hepatology.

In The Last Decade

Mayuko Kondo

31 papers receiving 974 citations

Hit Papers

Sarcopenia, intramuscular fat deposition, and visceral ad... 2015 2026 2018 2022 2015 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mayuko Kondo Japan 14 433 359 302 221 213 32 977
Tatsuya Minami Japan 14 428 1.0× 401 1.1× 375 1.2× 156 0.7× 200 0.9× 35 1.0k
Ángel Segura Spain 15 182 0.4× 237 0.7× 74 0.2× 143 0.6× 462 2.2× 45 881
Rohan Gupta United States 15 173 0.4× 95 0.3× 82 0.3× 311 1.4× 503 2.4× 50 932
Viniyendra Pamecha India 20 103 0.2× 374 1.0× 837 2.8× 729 3.3× 282 1.3× 95 1.2k
Philippe Compagnon France 27 294 0.7× 550 1.5× 1.2k 3.8× 1.3k 5.7× 519 2.4× 82 2.1k
Sagrario Soriano Spain 20 123 0.3× 203 0.6× 131 0.4× 136 0.6× 42 0.2× 37 1.1k
Ioannis D. Kostakis Greece 19 68 0.2× 273 0.8× 375 1.2× 553 2.5× 398 1.9× 85 1.3k
Jiayin Yang China 19 105 0.2× 1.3k 3.5× 1.2k 4.0× 403 1.8× 265 1.2× 66 1.8k
Shaum Kabadi United States 16 84 0.2× 197 0.5× 65 0.2× 91 0.4× 86 0.4× 36 663
Tomoyuki Matsunaga Japan 23 230 0.5× 113 0.3× 46 0.2× 638 2.9× 757 3.6× 137 1.7k

Countries citing papers authored by Mayuko Kondo

Since Specialization
Citations

This map shows the geographic impact of Mayuko Kondo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mayuko Kondo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mayuko Kondo more than expected).

Fields of papers citing papers by Mayuko Kondo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mayuko Kondo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mayuko Kondo. The network helps show where Mayuko Kondo may publish in the future.

Co-authorship network of co-authors of Mayuko Kondo

This figure shows the co-authorship network connecting the top 25 collaborators of Mayuko Kondo. A scholar is included among the top collaborators of Mayuko Kondo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mayuko Kondo. Mayuko Kondo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liang, Hai, David Connor, Heather Campbell, et al.. (2022). A novel flow cytometry procoagulant assay for diagnosis of vaccine-induced immune thrombotic thrombocytopenia. Blood Advances. 6(11). 3494–3506. 18 indexed citations
2.
Chan, Melissa V., Paul C. Armstrong, Marilena Crescente, et al.. (2022). A pilot study assessing the implementation of 96-well plate-based aggregometry (Optimul) in Australia. Pathology. 54(6). 746–754. 4 indexed citations
3.
Arai, Junya, Jun Kato, Nobuo Toda, et al.. (2021). Risk factors of poor prognosis and impairment of activities of daily living in patients with hemorrhagic gastroduodenal ulcers. BMC Gastroenterology. 21(1). 2 indexed citations
4.
Favaloro, Emmanuel J., et al.. (2021). Effect of sample heat inactivation on test levels of HIT-IgG(PF4-H) detected by the ACL AcuStar. Thrombosis Research. 200. 12–15.
5.
Ohki, Takamasa, Koki Sato, Mayuko Kondo, et al.. (2020). Impact of Adverse Events on the Progression-Free Survival of Patients with Advanced Hepatocellular Carcinoma Treated with Lenvatinib: A Multicenter Retrospective Study. Drugs - Real World Outcomes. 7(2). 141–149. 28 indexed citations
6.
Favaloro, Emmanuel J., Soma Mohammed, Mayuko Kondo, et al.. (2020). A multicentre assessment of contemporary laboratory assays for heparin induced thrombocytopenia. Pathology. 53(2). 247–256. 21 indexed citations
7.
Kawamura, Satoshi, Nobuo Toda, Yousuke Nakai, et al.. (2020). Impact of the Sensitivity to Empiric Antibiotics on Clinical Outcomes after Biliary Drainage for Acute Cholangitis. Gut and Liver. 14(6). 842–849. 6 indexed citations
8.
Rabbolini, David J., David Connor, Marie‐Christine Morel‐Kopp, et al.. (2020). An integrated approach to inherited platelet disorders: results from a research collaborative, the Sydney Platelet Group. Pathology. 52(2). 243–255. 15 indexed citations
9.
Arai, Junya, Jun Kato, Nobuo Toda, et al.. (2020). Long-term survival after palliative argon plasma coagulation for intraductal papillary mucinous neoplasm of the bile duct. Clinical Journal of Gastroenterology. 14(1). 314–318. 6 indexed citations
10.
Ohki, Takamasa, Jun Kato, Makoto Imai, et al.. (2020). Hepatitis C virus relapse after successful treatment with direct-acting antivirals, followed by sarcomatous changes in hepatocellular carcinoma: a case report. Journal of Medical Case Reports. 14(1). 62–62. 4 indexed citations
11.
Ohki, Takamasa, Koki Sato, Mayuko Kondo, et al.. (2020). Relationship between outcomes and relative dose intensity of lenvatinib treatment in patients with advanced hepatocellular carcinoma. Liver Research. 4(4). 199–205. 5 indexed citations
12.
Enooku, Kenichiro, Hayato Nakagawa, Naoto Fujiwara, et al.. (2019). Altered serum acylcarnitine profile is associated with the status of nonalcoholic fatty liver disease (NAFLD) and NAFLD-related hepatocellular carcinoma. Scientific Reports. 9(1). 10663–10663. 72 indexed citations
13.
Favaloro, Emmanuel J., Georgia McCaughan, Soma Mohammed, et al.. (2018). HIT or miss? A comprehensive contemporary investigation of laboratory tests for heparin induced thrombocytopenia. Pathology. 50(4). 426–436. 32 indexed citations
14.
Ohki, Takamasa, Mayuko Kondo, Satoshi Kawamura, et al.. (2017). Evaluation of the Efficacy of Sorafenib on Overall Survival in Patients with Hepatocellular Carcinoma using FT Rate: A Devised Index. Advances in Therapy. 34(5). 1097–1108. 7 indexed citations
15.
Fujiwara, Naoto, Hayato Nakagawa, Yotaro Kudo, et al.. (2015). Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma. Journal of Hepatology. 63(1). 131–140. 544 indexed citations breakdown →
16.
Fujiwara, Naoto, Ryosuke Tateishi, Mayuko Kondo, et al.. (2014). Cause-specific mortality associated with aging in patients with hepatocellular carcinoma undergoing percutaneous radiofrequency ablation. JONA The Journal of Nursing Administration. 44. 1039–1046. 1 indexed citations
17.
Fujiwara, Naoto, Ryosuke Tateishi, Mayuko Kondo, et al.. (2014). Cause-specific mortality associated with aging in patients with hepatocellular carcinoma undergoing percutaneous radiofrequency ablation. European Journal of Gastroenterology & Hepatology. 26(9). 1039–1046. 10 indexed citations
18.
Kondo, Mayuko, Takeaki Ishizawa, Kenichiro Enooku, et al.. (2014). Increased serum autotaxin levels in hepatocellular carcinoma patients were caused by background liver fibrosis but not by carcinoma. Clinica Chimica Acta. 433. 128–134. 33 indexed citations
19.
Asaoka, Yoshinari, Ryosuke Tateishi, Ryo Nakagomi, et al.. (2014). Frequency of and Predictive Factors for Vascular Invasion after Radiofrequency Ablation for Hepatocellular Carcinoma. PLoS ONE. 9(11). e111662–e111662. 23 indexed citations
20.
Sato, Masaya, Mayuko Kondo, Ryosuke Tateishi, et al.. (2014). Impact of IL28B Genetic Variation on HCV-Induced Liver Fibrosis, Inflammation, and Steatosis: A Meta-Analysis. PLoS ONE. 9(3). e91822–e91822. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026